News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
845,458 Results
Type
Article (86435)
Company Profile (702)
Press Release (758321)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232648)
Career Advice (4126)
Deals (39715)
Drug Delivery (129)
Drug Development (90977)
Employer Resources (198)
FDA (18097)
Job Trends (17328)
News (396405)
Policy (39738)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (16)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (92)
Alliances (56815)
ALS (99)
Alzheimer's disease (1496)
Antibody-drug conjugate (ADC) (156)
Approvals (18062)
Artificial intelligence (318)
Autoimmune disease (29)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (481)
Bladder cancer (83)
Brain cancer (31)
Breast cancer (296)
Cancer (2369)
Cardiovascular disease (201)
Career advice (3532)
Career pathing (34)
CAR-T (167)
Cell therapy (474)
Cervical cancer (21)
Clinical research (73330)
Collaboration (894)
Compensation (541)
Complete response letters (30)
COVID-19 (2863)
CRISPR (45)
C-suite (256)
Cystic fibrosis (107)
Data (2190)
Decentralized trials (2)
Denatured (45)
Depression (54)
Diabetes (291)
Diagnostics (6912)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (126)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (96465)
Editorial (43)
Employer branding (25)
Employer resources (167)
Events (129720)
Executive appointments (755)
FDA (19389)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (809)
Gene editing (115)
Generative AI (35)
Gene therapy (343)
GLP-1 (848)
Government (5154)
Grass and pollen (6)
Guidances (53)
Healthcare (20884)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (143)
Indications (29)
Infectious disease (3024)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (98)
Interviews (812)
IPO (17807)
IRA (51)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (550)
Leadership (22)
Legal (10113)
Liver cancer (79)
Lung cancer (338)
Lymphoma (155)
Machine learning (6)
Management (65)
Manufacturing (344)
MASH (73)
Medical device (14623)
Medtech (14628)
Mergers & acquisitions (22432)
Metabolic disorders (774)
Multiple sclerosis (84)
NASH (23)
Neurodegenerative disease (109)
Neuropsychiatric disorders (34)
Neuroscience (2083)
NextGen: Class of 2025 (7682)
Non-profit (5078)
Northern California (2675)
Now hiring (40)
Obesity (419)
Opinion (274)
Ovarian cancer (76)
Pain (95)
Pancreatic cancer (84)
Parkinson's disease (159)
Partnered (24)
Patents (245)
Patient recruitment (109)
Peanut (51)
People (65243)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22620)
Phase II (31831)
Phase III (23998)
Pipeline (1194)
Policy (167)
Postmarket research (3552)
Preclinical (10180)
Press Release (72)
Prostate cancer (106)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (424)
Real estate (7392)
Recruiting (75)
Regulatory (26756)
Reports (57)
Research institute (2657)
Resumes & cover letters (649)
Rett syndrome (4)
RNA editing (4)
RSV (50)
Schizophrenia (78)
Series A (142)
Series B (89)
Service/supplier (30)
Sickle cell disease (58)
Southern California (2318)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4290)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (38)
The Weekly (82)
United States (24149)
Vaccines (802)
Venture capitalists (44)
Weight loss (301)
Women's health (40)
Worklife (19)
Date
Today (99)
Last 7 days (718)
Last 30 days (2516)
Last 365 days (35839)
2025 (10997)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (59)
Alaska (7)
Arizona (267)
Arkansas (14)
Asia (50098)
Australia (8824)
California (6249)
Canada (2017)
China (550)
Colorado (279)
Connecticut (295)
Delaware (153)
Europe (114855)
Florida (910)
Georgia (216)
Hawaii (1)
Idaho (64)
Illinois (615)
India (31)
Indiana (330)
Iowa (12)
Japan (164)
Kansas (109)
Kentucky (27)
Louisiana (14)
Maine (70)
Maryland (946)
Massachusetts (4806)
Michigan (243)
Minnesota (414)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (69)
New Jersey (1777)
New Mexico (31)
New York (1773)
North Carolina (1113)
North Dakota (8)
Northern California (2675)
Ohio (214)
Oklahoma (15)
Oregon (48)
Pennsylvania (1381)
Puerto Rico (12)
Rhode Island (35)
South America (1652)
South Carolina (23)
South Dakota (1)
Southern California (2318)
Tennessee (104)
Texas (940)
Utah (188)
Virginia (168)
Washington D.C. (69)
Washington State (597)
West Virginia (3)
Wisconsin (66)
There are 845,458 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bladder cancer
Pfizer’s Subcutaneous PD-1 Cuts Risks in Bladder Cancer but Misses OS Endpoint
Pfizer’s sasanlimab, when used with standard of care, reduced the likelihood of disease recurrence or progression, death due to any cause or persistence of cancer cells by 32% in patients with high-risk non-muscle invasive bladder cancer.
April 28, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
Moss Genomics Launches “Perennial” Genomics Platform, Closes on 130 ETH
April 28, 2025
·
7 min read
Press Releases
Theralase Discovers New Mechanism of Action of Lead Drug
Theralase(R) Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar’s(TM) Ability to Inhibit DeUbiquitinating Enzymes, an Important Class of Enzymes Which Have Been Linked to Numerous Cancers and Neurogenerative Diseases
April 28, 2025
·
7 min read
Press Releases
American Aires Announces Record Q4 and Annual 2024 Order Volume
April 28, 2025
·
18 min read
Bladder cancer
J&J Declares ‘Sustained Disease Control’ With Bladder Cancer Drug-Device Combo
The targeted drug release device TAR-200 shows promising response and disease-free survival rates in specific populations of patients with non-muscle-invasive bladder cancer.
April 28, 2025
·
2 min read
·
Tristan Manalac
Drug Development
AACR 2025 Tracker: GSK, Boehringer Ingelheim Kick Off Meeting With New Data
With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect potentially practice-changing data in head and neck and lung cancer and key updates on hot modalities.
April 28, 2025
·
2 min read
·
BioSpace Editorial Staff
Cancer
Perioperative Keytruda Cuts Risk of Negative Events by Over 25% in Head and Neck Cancer
The FDA is currently reviewing Merck’s sBLA for Keytruda in head and neck cancer, with a target action date of June 23.
April 28, 2025
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
Merck KGaA Moves Ahead on SpringWorks Buy for $3.9B
The transaction is expected to close in the second half of 2025. With the deal, Merck KGaA is adding to its rare disease and oncology pipelines.
April 28, 2025
·
3 min read
·
Tristan Manalac
Cancer
Summit, Akeso’s Keytruda Challenger Wins Chinese OK as US Approval Questions Linger
With ivonescimab’s data coming solely from China, its prospects in the U.S., where Summit owns the rights, remain up in the air.
April 28, 2025
·
3 min read
·
Tristan Manalac
1 of 84,546
Next
